Glycaemic variability in paediatric patients with type 1 diabetes on continuous subcutaneous insulin infusion (<scp>CSII</scp>) or multiple daily injections (<scp>MDI</scp>): a cross‐sectional cohort study

Abstract

Paediatric patients with type 1 diabetes using an insulin pump presented with lower glycaemic variability and a concomitantly lower glycaemic risk parameter compared with those using MDII. Whether these findings translate into a lower risk of diabetes associated cardiovascular complications remains to be elucidated.